Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-24T22:11:36.067Z Has data issue: false hasContentIssue false
  • English
  • Français

Transferable plasmid-mediated drug resistance among non-O1 Vibrio cholerae and rough strains of Vibrio cholerae from Tamilnadu, India

Published online by Cambridge University Press:  19 October 2009

SP. Sundaram  and
K. V. Murthy
SP. Sundaram
Affiliation:
King Institute of Preventive Medicine, Guindy, Madras-600 032, India
K. V. Murthy
Affiliation:
King Institute of Preventive Medicine, Guindy, Madras-600 032, India
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A total of 289 non-O1 Vibrio cholerae (NVC) strains and 20 rough V. cholerae (RVC) strains isolated in an endemic area were tested for antibiotic resistance and for transferable R-plasmids. Twenty three per cent of NVC and 40% of the RVC isolates were found to be resistant to one or more drugs. Eight NVC and four RVC strains possessed multiple drug resistance, varying from four to eight drugs. The common spectrum found in NVC isolates were chloramphenicol and streptomycin (CS) or chloramphenicol, streptomycin, tetracycline and ampicillin (CSTA). Resistance to sulphamethoxazole (Su) and to trimethoprim (Tm) was encountered infrequently. In RVC isolates in addition CSTASuTm determinants, resistance markers to aminoglycosides kanamycin, gentamicin and neomycin were also found. Eighteen of the 27 V. cholerae strains with two or more resistance determinants transferred them en bloc to Escherichia coli K12. The level of resistance in the recipient strain was equal to or greater than that of the donor vibrio strains. Most of the strains possessing solitary resistance markers were unable to transfer them. βlactamase production could be demonstrated in 92·8% of the ampicillin resistant strains. None of the strains was resistant to nalidixic acid or furazolidone. The results emphasize the importance of antimicrobic susceptibility determination of V. cholerae isolates, regardless of the serotypes, before commencing chemotherapy.

Type
Research Article
Information
Journal of Hygiene , Volume 92 , Issue 1 , February 1984 , pp. 59 - 65
Copyright
Copyright © Cambridge University Press 1984

References

REFERENCES

Aldova, E., Laznickova, K., Stepankova, E. & Lietava, J. (1968). Isolation of nonagglutinable vibrios from an enteritis outbreak in Czechoslovakia. Journal of Infectious Diseases 118, 25–31.CrossRefGoogle ScholarPubMed
Barua, D. (1974). Laboratory diagnosis of cholera. In Cholera (ed. Barua, D. & Burrows, W.), p. 101. Philadelphia: W. B. Saunders.Google Scholar
El-Shawi, N. & Thewaini, A. J. (1969). Non-agglutinable vibrios isolated in the 1966 epidemic of cholera in Iraq. Bulletin of the World Health Organization 40, 163–166.Google Scholar
Glass, R. I., Huq, I., Alim, A. R. M. A. & Yunus, M. (1980). Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. Journal of Infectious Diseases 142, 939–942.CrossRefGoogle ScholarPubMed
Hedges, R. W. & Jacob, A. E. (1975). A 98 megadalton R factor of compatibility group C in a Vibrio cholerae ElTor isolate from Southern USSR. Journal of General Microbiology 89, 383–386.CrossRefGoogle Scholar
Hedges, R. W., Vialard, J. L., Pearson, N. J. & O'Grady, F. (1977). R Plasmids from Asian strains of Vibrio cholerae. Antimicrobial Agents and Chemotherapy 11, 585–588.CrossRefGoogle ScholarPubMed
Kuwahara, S., Goto, S., Kimura, M. & Abe, H. (1967). Drug sensitivity of El Tor vibrio strains isolated in Philippines in 1964 and 1965. Bulletin of the World Health Organization 37, 763–771.Google ScholarPubMed
Lucas, T. J. (1979). An evaluation of 12 methods for the demonstration of pencillinase. Journal of Clinical Pathology 32, 1061–1065.CrossRefGoogle Scholar
Matsen, J. M. & Barry, A. L. (1974). Susceptibility testing: Diffusion test procedures. In Manual of Clinical Microbiology, 2nd ed. (ed. Lennette, E. H., Spaulding, E. H. & Traunt, J. P.), pp. 418–427. Washington D.C.: American Society for Microbiology.Google Scholar
Misra, B. S., Varma, S. N., Mondal, M. M., Pal, S. C. & Raghavan, N. G. S. (1970). Antibiotic sensitivity pattern of vibrio strains isolated from different parts of India during 1968. Journal of Indian Medical Association 55, 311–313.Google ScholarPubMed
Mhalu, F. S., Mmari, P. W. & Ijumba, J. (1979). Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during the first six months of fourth cholera epidemic in Tanzania. Lancet i, 345–347.CrossRefGoogle Scholar
Prescott, L. M., Datta, A. & Datta, G. C. (1968). R-Factors in Calcutta strains of Vibrio cholerae and members of the Enterobacteriaceae. Bulletin of the World Health Organization 39, 971–973.Google ScholarPubMed
Shimada, T. & Sakazaki, R. (1973). R-Antigen of Vibrio cholerae. Japanese Journal of Medical Science and Biology 26, 155–160.CrossRefGoogle ScholarPubMed
Sil, J., Sanyal, S. C. & Mukherjee, S. (1974). Antibiotic sensitivity of Vibrio cholerae other than O Serotype 1 (So-called NAG Vibrios.) Indian Journal of Medical Research 62, 491–496.Google Scholar
Sundaram, SP., Shanthakumari, S. L. & Murthy, K. V. (1980). A study on Vibrio cholerae strains isolated in Tamilnadu during 1976–79. Indian Journal of Medical Research 72, 480–486.Google Scholar
Threlfall, E. J., Rowe, B. & Huq, I. (1980). Plasmid-encoded multiple antibiotic resistance in Vibrio cholerae El Tor from Bangladesh. Lancet i, 1247–1248.CrossRefGoogle Scholar
Threlfall, E. J. & Rowe, B. (1982). Vibrio cholerae El Tor acquires plasmid-encoded resistance to gentamicin. Lancet i, 42.CrossRefGoogle Scholar
Towner, K. J., Pearson, N. J. & O'Grady, F. (1979). Resistant Vibrio cholerae El Tor in Tanzania. Lancet ii, 147–148.CrossRefGoogle Scholar
World Health Organization (1978). Surveillance for the prevention and control of health hazards due to antibiotic resistant enterobacteria. WHO Technical Report Series 624, 49.Google Scholar